Skip to main content

Table 2 Susceptibility of oral Capnocytophaga spp. isolated from 1993 to 2002 (Hôpital Sud, Rennes, France). Susceptibility testing was determined by standard methods and break points according to the criteria of NCCLS [13] and Bremmelgaard et al. [12]

From: Prevalence of oropharyngeal beta-lactamase-producing Capnocytophagaspp. in pediatric oncology patients over a ten-year period

Year

Number of Resistant or Intermediate Capnocytophagastrains (%) (Total number of Capnostrains = 440)

 

Amoxicillin MIC1> 4 μg/ml

Ceftazidime MIC > 4 μg/ml

1993

31 (88)

28 (80)

1994

31 (84)

28 (75)

1995

11 (100)

11 (100)

1996

6 (100)

5 (83)

1997

10 (100)

9 (90)

1998

27 (96)

20 (71)

1999

23 (85)

10 (37)

2000

16 (84)

12 (63)

2001

54 (80)

38 (56)

2002

56 (81)

34 (49)

Total

265 (86)

195 (63)

  1. Note: No strains were resistant to an imipenem and amoxicillin/clavulanic acid combination, and all beta-lactamase-producing strains were resistant to cefazolin.
  2. 1: Minimal Inhibitory Concentration (μg/ml).